Table 2.
Multivariate Cox regression analysis† for the risk factors associated with the survival in induction therapy based on primary cohort.
| HR | 95% CI | P-value | |
|---|---|---|---|
| Age >18 years | 1.24 | 1.08–1.42 | 0.040 |
| GGT | Omitted | ||
| Cr | Omitted | ||
| Bun | 1.08 | 1.02–1.13 | 0.015 |
| PCT >2 µg/L | 2.60 | 1.49–4.55 | 0.001 |
| sCD25, ×104 | 1.08 | 1.02–1.14 | 0.010 |
| EBV-DNA in PBMC, ×105 | 1.10 | 1.05–1.16 | <0.001 |
†The multivariate Cox regression analysis was performed using backward method.
HR, hazard ratio; GGT, gamma-glutamyl transpeptidase; Cr, creatinine; Bun, blood urea nitrogen; PCT, procalcitonin; serum CD25; EBV, Epstein–Barr virus; DNA, deoxyribonucleic acid; PBMC, peripheral blood mononuclear cell.